Huaying Dong - Publications

Retraction Note: Exosome-transmitted miR-567 reverses trastuzumab resistance by inhibiting ATG5 in breast cancer.

Journal: Cell death & disease

Published: November 10, 2023

Bioinformatic analysis and experimental validation of six cuproptosis-associated genes as a prognostic signature of breast cancer.

Journal: PeerJ

Published: October 10, 2023

Retraction Note: MSC-induced lncRNA AGAP2-AS1 promotes stemness and trastuzumab resistance through regulating CPT1 expression and fatty acid oxidation in breast cancer.

Journal: Oncogene

Published: July 07, 2023

Prognostic value of RNA methylation-related genes in gastric adenocarcinoma based on bioinformatics.

Journal: PeerJ

Published: July 06, 2023

16S full-length gene sequencing analysis of intestinal flora in breast cancer patients in Hainan Province.

Journal: Molecular and cellular probes

Published: June 01, 2023

Pathological complete response rate and clinical outcome after neoadjuvant therapy of HER2-low breast cancer: A National Cancer Database Analysis.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: April 12, 2023

Breast cancer-derived exosomal lncRNA SNHG14 induces normal fibroblast activation to cancer-associated fibroblasts via the EBF1/FAM171A1 axis.

Journal: Breast cancer (Tokyo, Japan)

Published: February 15, 2023

Retraction Note: SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88.

Journal: Journal of experimental & clinical cancer research : CR

Published: January 11, 2023

Exploration of prognostic genes and risk signature in breast cancer patients based on RNA binding proteins associated with ferroptosis.

Journal: Frontiers in genetics

Published: August 22, 2022

Retraction Note to: Exosome-mediated lncRNA AFAP1-AS1 promotes trastuzumab resistance through binding with AUF1 and activating ERBB2 translation.

Journal: Molecular cancer

Published: July 12, 2022

Retraction Note to: Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer.

Journal: Molecular cancer

Published: June 29, 2022

A commentary on "Intraoperative pathologically-calibrated diagnosis of lymph nodes involved by breast cancer cells based on electrical impedance spectroscopy; a prospective diagnostic human model study" (Int J Surg 2021;96:106166).

Journal: International journal of surgery (London, England)

Published: June 27, 2022